September 19, 2022
Vancouver based healthtech startup, Curatio, has merged with Australian medtech firm, RxMx, to form RxPx. The merger was backed by Pemba Capital Partners, a private equity firm that acquired a majority stake in RxMx last year.
The company name, RxPx stands for prescription medication and patient experience. RxPx aims to provide elevated solutions to patients, with a focus on patients who participate in specialty therapies to treat serious diseases. Lynda Brown-Ganzert, founder and CEO of Curatio and now the CEO for RxPx, stressed the importance of ensuring that patients and doctors are supported: “No patient should be alone and without support when dealing with a health challenge, and no doctor should be without the tools to easily and safely onboard their patient onto a new therapy or program.”
The service focuses on meeting the privacy, security and compliance needs of healthcare organizations. RxPx is available in over 100 countries and in 15 languages. With six different platforms to choose from, healthcare organizations can tailor their services to best provide class therapy management and patient support. This could include programs, therapy, initiatives for clinics, or memberships. With the recent push to virtual healthcare caused by COVID-19, it will be interesting to see the impact that RxPx has on both patient well-being and the needs of healthcare providers.
Caroline Jordan, 2022 Articling Student-at-Law